Calendar Beximco Pharmaceuticals Limited London S.E.

Equities

BXP

US0885792061

Market Closed - London S.E. 11:35:12 2024-04-26 am EDT 5-day change 1st Jan Change
36.5 GBX 0.00% Intraday chart for Beximco Pharmaceuticals Limited -1.35% -12.05%

Chart calendar Beximco Pharmaceuticals Limited

0b5b42eb617cbc3e671b15bdb.-HxpqgY5qP1-WLXh2QrQHQGFDYoP4QMjrn_PQ29fqnY.ljQD3ktJ0sQML9iummaedDXmQtNFrVxzzAugBRtt-DKBKjDNMHTRlxBr1g~ee688bffd7088442835bbd7e1f3e8e9a

Upcoming events on Beximco Pharmaceuticals Limited

2024-11-06 Q1 2025 Earnings Release (Projected)
2024-11-11 Q4 2024 Earnings Release (Projected)
2025-01-28 Q2 2025 Earnings Release (Projected)

Past events on Beximco Pharmaceuticals Limited

2024-04-25 Q3 2024 Earnings Release (Projected)
2024-01-30 02:00 am Q2 2024 Earnings Release
2023-12-28 05:30 am Annual General Meeting
2023-11-13 Ex-dividend day for final dividend
2023-11-06 02:00 am Q1 2024 Earnings Release
2023-10-20 02:00 am Q4 2023 Earnings Release
2023-05-02 02:00 am Q3 2023 Earnings Release
2023-01-30 02:00 am Interim 2023 Earnings Release
2022-12-21 11:30 pm Annual General Meeting
2022-11-21 Ex-dividend day for final dividend
2022-11-11 02:00 am Q1 2023 Earnings Release
2022-10-28 02:00 am FY 2022 Earnings Release
2022-04-28 02:00 am Q3 2022 Earnings Release
2022-01-28 02:00 am Interim 2022 Earnings Release
2021-12-22 11:30 pm Annual General Meeting
2021-11-22 Ex-dividend day for final dividend
2021-11-11 05:30 am Q1 2022 Earnings Release
2021-11-02 03:00 am FY 2021 Earnings Release
2021-04-29 Q3 2021 Earnings Release
2021-01-28 02:00 am Interim 2021 Earnings Release

Past dividends on Beximco Pharmaceuticals Limited

2023-11-13 Annual 3.5 BDT
2022-11-21 Annual 3.5 BDT
2021-11-22 Annual 3.5 BDT
2020-11-25 Annual 1.5 BDT
2019-11-25 Annual 1.5 BDT
2018-11-26 Annual 1.25 BDT
2017-11-15 Annual 1.25 BDT
2016-11-01 Final Payment 0.5 BDT
2016-05-14 Interim Payment 1 BDT
2015-05-23 Annual 1 BDT

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023 2024
Net sales
Million BDT
Released
Forecast
Spread
22 817
22 373
1.98%
25 612
25 468
0.57%
29 494
29 285
0.71%
34 669
34 396
0.79%
39 267
38 191
2.82%

44 551

EBITDA
Million BDT
Released
Forecast
Spread
6 009
5 759
4.34%
6 723
6 464
4.01%
7 765
8 132
-4.51%
8 543
8 951
-4.56%
0,00
0,00
-

9 785

EBIT
Million BDT
Released
Forecast
Spread
5 066
4 786
5.85%
5 609
5 348
4.9%
6 651
7 029
-5.38%
6 901
7 780
-11.29%
7 216
7 297
-1.11%

7 905

Earnings before Tax (EBT)
Million BDT
Released
Forecast
Spread
3 946
3 856
2.34%
4 653
4 470
4.1%
6 378
6 726
-5.18%
6 687
8 306
-19.49%
6 069
6 645
-8.67%

6 915

Net income
Million BDT
Released
Forecast
Spread
3 033
2 941
3.14%
3 515
3 395
3.54%
5 141
5 011
2.59%
5 123
6 387
-19.79%
4 612
5 151
-10.47%

5 132

EPS
BDT
Released
Forecast
Spread
6,80
6,64
2.47%
7,88
7,59
3.87%
11,5
11,2
2.32%
11,5
12,3
-6.67%
10,3
0,00
-

12,3

Announcement Date11/11/1911/11/2002/11/2108/11/2201/11/23-

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BXPHARMA Stock
  4. BXP Stock
  5. Calendar Beximco Pharmaceuticals Limited